882757-24-6 Usage
Uses
Used in Chemical Synthesis:
N,N'-[[5-[2-Amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]phosphinylidene]bis[2-methylalanine] diethyl ester is used as a synthetic intermediate for the creation of complex organic molecules, taking advantage of its multiple reactive sites to facilitate various chemical reactions.
Used in Pharmaceutical Research:
In the pharmaceutical industry, N,N'-[[5-[2-Amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]phosphinylidene]bis[2-methylalanine] diethyl ester may be utilized as a lead compound for drug development, given its unique structure and potential biological activity. Further research is required to determine its specific properties and therapeutic potential.
Used in Material Science:
N,N'-[[5-[2-Amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]phosphinylidene]bis[2-methylalanine] diethyl ester could be employed in the development of new materials, such as polymers or coatings, that leverage its reactive sites and structural features for enhanced properties or specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 882757-24-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,7,5 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 882757-24:
(8*8)+(7*8)+(6*2)+(5*7)+(4*5)+(3*7)+(2*2)+(1*4)=216
216 % 10 = 6
So 882757-24-6 is a valid CAS Registry Number.
882757-24-6Relevant articles and documents
CRYSTALLINE POLYMORPHS
-
Page/Page column 182-183, (2009/03/07)
The present invention provides for crystalline forms of 2-amino-5-(2,2- dimethylpropionyl)-4-{[5-(N,N'-(2-ethoxycarbonylprop-2-yl)phosphonamido] furan-2-yl}thiazole and compositions thereof including pharmaceutical compositions. The present invention further provides for methods of using and processes for making the same.
Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
-
Page/Page column 25, (2010/11/28)
Compounds of Formula I, their prodrugs and salts, their preparation and their uses are described.